RREGNRegeneron Pharmaceuticals Tokenized Stock (Reality)
Stock 24/7/365Issued by Reality
Regeneron Pharmaceuticals engages in the research, development, manufacturing, and sale of prescription drugs. Its medications are primarily used to treat eye diseases, atopic dermatitis, asthma, and certain tumors. Additionally, the company has clinical-stage product candidates in autoimmune and cardiovascular diseases. The company relies on its proprietary genetic technologies and external corporate partnerships to advance the clinical testing and regulatory review procedures of related medical projects.
- Macro context: RREGN is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.
Data as of Nov 1, 2026
Price performance
7D
—
14D
—
30D
—
1Y
—
All-time
+23.81%
Market Cap
$43.62
24h Volume
$59.6
Key facts
via /coins/{id}Market Cap Rank
#16126
Circulating Supply
0.05
Total Supply
0.05
All-Time High
$972.7 · 2026-11-02
Categories
News & Insights
Also tokenized by
Regeneron Pharmaceuticals Tokenized Stock (Reality) is issued as 3 separate tokens across different issuers.
| Issuer | Token | Price | Market Cap | 24h Volume | Networks |
|---|---|---|---|---|---|
| Ondo Finance | $964.08 | $16.25K | $162.24K |    | |
| xStocks | REGREGNX | — | — | — | — |
REGNONAlerts & digests
Coming soonReal-time price, NAV, mint, redemption alerts
Get pinged the moment RREGN crosses a price or spread threshold you set, or automated.
Breaking news alerts
Issuer, regulatory and depeg news for RREGN — the second it drops.
Daily summary
A once-a-day digest of RREGN's price, best yield and market moves in your inbox.
Analyze & download 24/7 history
Full round-the-clock historical data for RREGN — including off-market-hours — exportable to CSV.
Analyse with insight & news
AI-assisted analysis of RREGN paired with the latest issuer, regulatory and market news.